MAFF alleviates hepatic ischemia–reperfusion injury by regulating the CLCF1/STAT3 signaling pathway
MAFF alleviates hepatic ischemia-reperfusion injury by reducing hepatocyte apoptosis and the inflammatory response through the activation of the CLCF1/STAT3 signaling pathway, offering valuable insights into the impact of MAFF on liver protection and potential therapeutic targets for liver treatment.
Authors
- Zhongjun Wu (ORCID: https://orcid.org/0000-0002-1627-0633)
- Dengliang Lei
- Luo Fang (ORCID: https://orcid.org/0000-0002-8070-5662)
- Zuotian Huang (ORCID: https://orcid.org/0000-0003-4688-5820)
- Yunhai Luo (ORCID: https://orcid.org/0000-0001-6948-2042)
- Shanshan Li (ORCID: https://orcid.org/0000-0002-3420-0567)
- Yihua Wang (ORCID: https://orcid.org/0000-0001-5561-0648)
- Ping Yan (ORCID: https://orcid.org/0000-0001-7523-9460)
- Song Xiang
Institutions
- Guiyang Medical University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Cellular & Molecular Biology Letters
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1186/s11658-025-00721-x
- Citations
- 8
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 7.49
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China